全文获取类型
收费全文 | 49575篇 |
免费 | 2834篇 |
国内免费 | 184篇 |
专业分类
耳鼻咽喉 | 636篇 |
儿科学 | 1231篇 |
妇产科学 | 1128篇 |
基础医学 | 6818篇 |
口腔科学 | 2923篇 |
临床医学 | 4110篇 |
内科学 | 11012篇 |
皮肤病学 | 1304篇 |
神经病学 | 4576篇 |
特种医学 | 1143篇 |
外国民族医学 | 1篇 |
外科学 | 5536篇 |
综合类 | 293篇 |
一般理论 | 13篇 |
预防医学 | 4764篇 |
眼科学 | 996篇 |
药学 | 3641篇 |
中国医学 | 322篇 |
肿瘤学 | 2146篇 |
出版年
2023年 | 377篇 |
2022年 | 853篇 |
2021年 | 1707篇 |
2020年 | 966篇 |
2019年 | 1504篇 |
2018年 | 1814篇 |
2017年 | 1218篇 |
2016年 | 1318篇 |
2015年 | 1522篇 |
2014年 | 2016篇 |
2013年 | 2595篇 |
2012年 | 3914篇 |
2011年 | 4147篇 |
2010年 | 2163篇 |
2009年 | 1746篇 |
2008年 | 3064篇 |
2007年 | 3053篇 |
2006年 | 2743篇 |
2005年 | 2552篇 |
2004年 | 2433篇 |
2003年 | 2055篇 |
2002年 | 1920篇 |
2001年 | 943篇 |
2000年 | 943篇 |
1999年 | 755篇 |
1998年 | 299篇 |
1997年 | 212篇 |
1996年 | 217篇 |
1995年 | 159篇 |
1994年 | 144篇 |
1993年 | 115篇 |
1992年 | 292篇 |
1991年 | 284篇 |
1990年 | 264篇 |
1989年 | 202篇 |
1988年 | 199篇 |
1987年 | 190篇 |
1986年 | 165篇 |
1985年 | 148篇 |
1984年 | 144篇 |
1983年 | 117篇 |
1982年 | 69篇 |
1981年 | 83篇 |
1980年 | 69篇 |
1979年 | 93篇 |
1978年 | 70篇 |
1975年 | 56篇 |
1971年 | 60篇 |
1969年 | 48篇 |
1967年 | 67篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
971.
972.
Vernica Frana Diniz Rocha Thiago Pereira Cavalcanti Jailton Azevedo Helena Ferreira Leal Giulyana Evelyn Oliveira Silva Allan Roberto Xavier Malheiros Ledilce Almeida Ataide Jos Admiro Lima Filho Antonio Raimundo Pinto Almeida Nadia de Andrade Khouri Mitermayer Galvo Reis Joice Neves Reis 《The American journal of tropical medicine and hygiene》2021,104(3):848
973.
Ins Mndez-Tovar Baudilio Herrero Silvia Prez-Magario Jos Alberto Pereira M. Carmen Asensio-S.-Manzanera 《Yao wu shi pin fen xi = Journal of food and drug analysis.》2015,23(2):225
The objective of this work was to evaluate the antioxidant properties of Lavandula latifolia waste obtained after essential oil distillation. Samples of 12 wild populations of the Lavandula genus collected between 2009 and 2010 were hydrodistilled and their by-products were analyzed using the Folin–Ciocalteu, free radical scavenging activity (2,2-diphenyl-1-picrylhydrazyl), and the ferric reducing antioxidant power (FRAP) methods. Rosmarinic acid, apigenin, and luteolin contents were analyzed by high-performance liquid chromatography–diode array detection. The mean of total phenolic content ranged from 1.89 ± 0.09 mg gallic acid equivalents/g dry weight to 3.54 ± 0.22 mg gallic acid equivalents/g dry weight. The average value of the half maximal effective concentration (EC50) for scavenging activity ranged from 5.09 ± 0.17 mg/mL to 14.30 ± 1.90 mg/mL and the variability of the EC50 in FRAP ranged from 3.72 ± 0.12 mg/mL to 18.55 ± 0.77 mg/mL. Annual variation was found among this samples and the environmental conditions of 2009 were found to be more favorable. The plants collected from Sedano showed the highest antioxidant power. Our results show that rosmarinic acid and apigenin in L. latifolia contributed to the antioxidant properties of the waste. In conclusion, the by-product of the distillation industry could be valorizing as a source of natural antioxidants. 相似文献
974.
975.
976.
977.
Joo Andr Ferreira Rui Miguel Baptista Sílvia Reis Monteiro Lino Manuel Gonalves 《Medicine》2021,100(3)
The use of beta-blockers (BB) in the context of ST-segment elevation myocardial infarction (STEMI) was a universal practice in the pre-reperfusion era. Since then, evidence of their use for secondary prevention after STEMI is scarce. Our aim is to determine treatment results associated with BB therapy after a STEMI at 1-year follow-up in a contemporary nationwide cohort.A prospective analysis involving 49 national centers, including patients admitted with STEMI, enrolled between October 2010 and September 2019 was conducted. The primary outcome was defined as the composite of all-cause mortality or hospital re-admission for a cardiovascular (CV) cause in the first year after STEMI. The patients were distributed into 2 groups, depending on whether they received therapy with BB at hospital discharge or not (BB and NB group, respectively).A total of 3145 patients were included in the analysis, of which 2526 (80.3%) in the BB group. A total of 12.2% of patients reached the primary outcome. Regarding the univariate Cox regression analysis, the BB group presented lower mortality or re-admission for CV cause at 1-year follow-up [hazard ratio (HR) 0.69, confidence interval (CI) 95% 0.55–0.87, P = .001]. However, after adjustment for significant covariates, this association was lost (HR 0.73, CI 95% 0.51–1.04, P = .081). In patients with preserved (HR 0.73, CI 95% 0.51–1.04, P = .081) and mid-range (HR 1.01, CI 95% 0.64–1.61, P = .959) left ventricular ejection fraction (LVEF), the primary outcome was similar between the 2 groups, while in patients with reduced LVEF, the BB group presented a better prognosis, with fewer patients reaching the primary outcome (HR 0.431, CI 95% 0.262–0.703, P = .001).BB universal therapy after STEMI has not proved useful, but it seems to be beneficial in patients with reduced LVEF. 相似文献
978.
Mehmet Serdar Dervişoğulları Yüksel Totan Aylin Tenlik Aslıhan Yüce Emre Güler 《Cutaneous and ocular toxicology》2015,34(4):282-285
Purpose: The aim of this study is to show the effects of smoking on retina layers, especially retina nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer complex (GCIPL).Materials and methods: Participants smoking for more than 10 years at least 1 pack of cigarettes a day and a control group, both including participants between ages of 20 and 50 years with no other systemic or ocular diseases were studied. After normality tests, an independent sample t test was used to analyze the differences in age, sex, spherical equivalent (SE), intraocular pressure (IOP), axial length (AL), GCIPL and RNFL values between the groups.Results: There were 44 participants in each group. There were 32 (62.5%) men and 12(37.5%) women in smokers and 36 (77.88%) men and 8 (22.22%) women in control group. Mean ages were 39.85?±?8.41 and 38.66?±?10.47 years, mean spherical equivalent (SE) values were ?0.15?±?0.4 and 0?±?0.29 dioptries in smokers and control groups, respectively. The IOP, AXL, GCIPL and RNFL values were 17.58?±?3.41?mmHg, 23.69?±?0.56?mm, 84.3?±?5.83?μm and 92.3?±?3.51?μm in the smokers group and 18.5?±?2.91?mmHg, 23.45?±?0.72?mm, 86.11?±?8.02?μm and 97.66?±?8.23?μm in the control group. The inferior, superior, nasal and temporal values of RNFL quadrants were 123.18?±?26.14, 117.05?±?5.51, 64.95?±?8.67 and 63.5?±?6.88?μm in the smokers group and 130.81?±?11.8, 123.55?±?11.03, 72.44?±?9.84 and 58.44?±?7.48?μm in the control group. There were no significant difference of age, sex, SE, IOP, AXL and GCIPL values between the smokers and control groups (p?>?0.05). The mean RNFL was significantly thinner in the smokers group compared to controls (p?=?0.03, independent t test). Inferior and superior quadrants of RNFL decreased in smokers group (p?=?0.01 and p?=?0.03, respectively) but temporal and nasal quadrants did not seem to be changed (p?=?0.96 and p?=?0.07, respectively).Discussion: Smoking may affect RNFL thickness but not GCIPL. 相似文献
979.
The relevance of tyrosine kinase inhibitors (TKIs) in the treatment of malignancies has
been already defined. Aberrant activation of tyrosine kinase signaling pathways has been causally
linked not only to cancers but also to other non-oncological diseases. This review concentrates on the
novel plausible usage of this group of drugs in neurological disorders, such as ischemic brain stroke,
subarachnoid hemorrhage, Alzheimer’s disease, multiple sclerosis. The drugs considered here are
representatives of both receptor and non-receptor TKIs. Among them imatinib and masitinib have the
broadest spectrum of therapeutic usage. Both drugs are effective in ischemic brain stroke and multiple
sclerosis, but only imatinib produces a therapeutic effect in subarachnoid hemorrhage. Masitinib and
dasatinib reduce the symptoms of Alzheimer’s disease. In the case of multiple sclerosis several TKIs are useful, including
apart from imatinib and masitinib, also sunitinib, sorafenib, lestaurtinib. Furthermore, the possible molecular targets for
the drugs are described in connection with the underlying pathophysiological mechanisms in the diseases in question. The
most frequent target for the TKIs is PDGFR which plays a pivotal role particularly in ischemic brain stroke and
subarachnoid hemorrhage. The collected data indicates that TKIs are very promising candidates for new therapeutic
interventions in neurological diseases. 相似文献
980.